Evidence map›Paper›PMID 28640877›Full record

ArticlePLoS pathogens2017

Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.

Anna M Marthaler, Marta Podgorska, Pascal Feld, Alina Fingerle, Katrin Knerr-Rupp, Friedrich Grässer, Hans Smola, Klaus Roemer, Elke Ebert, Yoo-Jin Kim and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. The Role of MicroRNAs in Epidermal Barrier.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Article
  13. Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  14. Review
  15. Article
  16. Review
  17. [Lichen ruber planus : Better understanding, better treatment!]Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2018
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Anna M MarthalerInstitute of Virology, Saarland University, Homburg/Saar, Germany.
Marta PodgorskaInstitute of Virology, Saarland University, Homburg/Saar, Germany.
Pascal FeldInstitute of Virology, Saarland University, Homburg/Saar, Germany.
Alina FingerleInstitute of Virology, Saarland University, Homburg/Saar, Germany.ORCID http://orcid.org/0000-0002-0500-8103
Katrin Knerr-RuppInstitute of Virology, Saarland University, Homburg/Saar, Germany.
Friedrich GrässerInstitute of Virology, Saarland University, Homburg/Saar, Germany.ORCID http://orcid.org/0000-0001-6234-5571
Hans SmolaHartmann AG, Heidenheim, Germany.ORCID http://orcid.org/0000-0002-8755-1598
Klaus RoemerJose Carreras Center for Immune and Gene Therapy, Saarland University Medical Center, Homburg/Saar, Germany.
Elke EbertInstitute of Pathology, Saarland University Medical Center, Homburg/Saar, Germany.
Yoo-Jin KimInstitute of Pathology, Saarland University Medical Center, Homburg/Saar, Germany.ORCID http://orcid.org/0000-0002-6444-2938
Rainer M BohleInstitute of Pathology, Saarland University Medical Center, Homburg/Saar, Germany.
Cornelia S L MüllerDepartment of Dermatology, Saarland University Medical Center, Homburg/Saar, Germany.
Jörg ReichrathDepartment of Dermatology, Saarland University Medical Center, Homburg/Saar, Germany.
Thomas VogtDepartment of Dermatology, Saarland University Medical Center, Homburg/Saar, Germany.
Magdalena MalejczykDiagnostic Laboratory of STDs, Department of Dermatology and Venereology, Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-4495-9745
Sławomir MajewskiDepartment of Dermatology and Venereology, Medical University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-6721-3743
Sigrun SmolaInstitute of Virology, Saarland University, Homburg/Saar, Germany.ORCID http://orcid.org/0000-0003-3289-6545
Saarland University · DEMedical University of Warsaw · PLUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients suffering from Epidermodysplasia verruciformis (EV), a rare inherited skin disease, display a particular susceptibility to persistent infection with cutaneous genus beta-human papillomavirus (beta-HPV), such as HPV type 8. They have a high risk to develop non-melanoma skin cancer at sun-exposed sites. In various models evidence is emerging that cutaneous HPV E6 proteins disturb epidermal homeostasis and support carcinogenesis, however, the underlying mechanisms are not fully understood as yet. In this study we demonstrate that microRNA-203 (miR-203), a key regulator of epidermal proliferation and differentiation, is strongly down-regulated in HPV8-positive EV-lesions. We provide evidence that CCAAT/enhancer-binding protein α (C/EBPα), a differentiation-regulating transcription factor and suppressor of UV-induced skin carcinogenesis, directly binds the miR-203 gene within its hairpin region and thereby induces miR-203 transcription. Our data further demonstrate that the HPV8 E6 protein significantly suppresses this novel C/EBPα/mir-203-pathway. As a consequence, the miR-203 target ΔNp63α, a proliferation-inducing transcription factor, is up-regulated, while the differentiation factor involucrin is suppressed. HPV8 E6 specifically down-regulates C/EBPα but not C/EBPβ expression at the transcriptional level. As shown in knock-down experiments, C/EBPα is regulated by the acetyltransferase p300, a well-described target of cutaneous E6 proteins. Notably, p300 bound significantly less to the C/EBPα regulatory region in HPV8 E6 expressing keratinocytes than in control cells as demonstrated by chromatin immunoprecipitation. In situ analysis confirmed congruent suprabasal expression patterns of C/EBPα and miR-203 in non-lesional skin of EV-patients. In HPV8-positive EV-lesions both factors are potently down-regulated in vivo further supporting our in vitro data. In conclusion our study has unraveled a novel p300/C/EBPα/mir-203-dependent mechanism, by which the cutaneous HPV8 E6 protein may expand p63-positive cells in the epidermis of EV-patients and disturbs fundamental keratinocyte functions. This may drive HPV-mediated pathogenesis and may potentially also pave the way for skin carcinogenesis in EV-patients.

Indexed as

CCAAT-Enhancer-Binding Protein-alphaCell LineCell Transformation, ViralChromatin ImmunoprecipitationElectrophoretic Mobility Shift AssayEpidermodysplasia VerruciformisGene Expression RegulationHumansImmunoblottingImmunohistochemistryIn Situ HybridizationKeratinocytesMicroRNAsOncogene Proteins, ViralPapillomavirus InfectionsReal-Time Polymerase Chain ReactionCCAAT-Enhancer-Binding Protein-alphaE6 protein, Human papillomavirus type 8MicroRNAsMIRN203 microRNA, humanOncogene Proteins, Viral

Identifiers

PMID28640877
PMCPMC5481020
OpenAlexW2708986944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.